Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending September 2013. The report specifically details a notification of transactions involving directors or persons discharging managerial responsibility (PDMR) under the Disclosure and Transparency Rule 3.1.4R(1)(c).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory notification regarding share transactions rather than a financial results report.
Material Changes
The filing reports a specific transaction on September 10, 2013, involving Mr. P C Thomson and Mrs. K Thomson. They acquired a total of 4 Ordinary Shares through the Company's ShareReward Plan at a price of 1586.85 pence per share. The acquisition consisted of:
- 2 Ordinary Shares under the personal contribution element.
- 2 Ordinary Shares under the matching element (Company contribution).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the disclosure of the specific share acquisition mentioned above.
Investor Verification Points
- Verify the total number of shares acquired by Mr. P C Thomson and Mrs. K Thomson (4 shares total).
- Confirm the transaction price of 1586.85 pence per Ordinary Share.
- Note that this filing does not contain financial performance data for the period.